The use of cimetidine to reduce dapsone‐dependent methaemoglobinaemia in dermatitis herpetiformis patients.

British Journal of Clinical Pharmacology - Tập 34 Số 3 - Trang 244-249 - 1992
Michael D. Coleman1, Lesley E. Rhodes1, AK Scott1, JL Verbov1, PS Friedmann1, AM Breckenridge1, BK Park1
1Department of Pharmacology and Therapeutics, Liverpool.

Tóm tắt

1. We have attempted to reduce dapsone‐dependent methaemoglobinaemia formation in six dermatitis herpetiformis patients stabilised on dapsone by the co‐administration of cimetidine. 2. In comparison with control, i.e. dapsone alone, methaemoglobinaemia due to dapsone fell by 27.3 +/‐ 6.7% and 26.6 +/‐ 5.6% the first and second weeks after commencement of cimetidine administration. The normally cyanotic appearance of the patient on the highest dose of dapsone (350 mg day‐ 1), underwent marked improvement. 3. There was a significant increase in the trough plasma concentration of dapsone (2.8 +/‐ 0.8 x 10(‐5)% dose ml‐1) at day 21 in the presence of cimetidine compared with control (day 7, 1.9 +/‐ 0.6 x 10(‐5)% dose ml‐1, P less than 0.01). During the period of the study, dapsone‐mediated control of the dermatitis herpetiformis in all six patients was unchanged. 4. Trough plasma concentrations of monoacetyl dapsone were significantly increased (P less than 0.05) at day 21 (1.9 +/‐ 1.0 x 10(‐5)% dose ml‐ 1) compared with day 7 (1.6 +/‐ 0.9 x 10(‐5)% dose ml‐1:control). 5. Over a 12 h period, 20.6 +/‐ 8.9% (day 0) of a dose of dapsone was detectable in urine as dapsone hydroxylamine. Significantly less dapsone hydroxylamine was recovered from urine at day 14 (15.0 +/‐ 8.4) in the presence of cimetidine, compared with day 0 (control: P less than 0.05). 6. The co‐administration of cimetidine may be of value in increasing patient tolerance to dapsone, a widely used, effective, but comparatively toxic drug.

Từ khóa


Tài liệu tham khảo

Bruce‐Chwatt L. J., 1982, Essential malariology, 181

10.1111/j.2042-7158.1990.tb05416.x

10.1111/j.2042-7158.1992.tb03573.x

10.1111/j.1365-2125.1990.tb03847.x

10.1002/ddr.430250102

10.1111/j.2042-7158.1991.tb06663.x

10.1016/0006-2952(90)90164-G

10.4269/ajtmh.1972.21.322

DeGowin R. L., 1966, The haemolytic effects of diphenylsulphone (DDS) in normal subjects and in those with glucose 6‐phosphate dehydrogenase deficiency, Bull. W.H.O., 35, 165

Ellard G. A., 1966, Absorption, metabolism and excretion of di(p‐aminophenyl) sulphone (dapsone) and di(p‐aminophenyl) sulphoxide in man, Br. J. clin. Pharmac., 26, 212

Ganer A., 1981, Dapsone induced methaemoglobinaemia and haemolysis in the presence of familial hemoglobinopathy hasharon and familial methaemoglobin reductase deficiency, Is. J. med. Sci., 17, 703

10.1002/cpt1971122part1225

Gordon J. R., 1979, Studies on the urinary metabolites of dapsone in man, Int. J. Leprosy, 47, 681

10.1111/j.1365-4362.1975.tb04283.x

Grindulis K. A., 1984, Rheumatoid arthritis, the effects of treatment with dapsone on haemoglobin, J. Rheumatol., 11, 776

Grossman S. J., 1988, Role of DDS NOH in dapsone‐induced haemolytic anaemia, J. Pharmac. exp. Ther., 244, 118

Harrison J. H., 1986, Role of aniline metabolites in aniline‐induced hemolytic anemia, J. Pharmac. exp. Ther., 238, 1045

Hornsten P., 1990, The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden 1972 through 1988, Arch. Dermatol., 126, 919, 10.1001/archderm.1990.01670310081011

Israili Z. H., 1973, Studies of the metabolism of DDS in man and experimental animals. Formation of N‐hydroxy metabolites, J. Pharmac. exp. Ther., 187, 138

Knodell R. G., 1991, Differential inhibition of individual human liver cytochromes P‐450 by cimetidine, Gastroenterology, 101, 1630, 10.1016/0016-5085(91)90408-D

10.1016/0006-2952(72)90288-2

10.7326/0003-4819-110-8-606

10.1111/j.1365-2133.1979.tb01644.x

10.1001/archderm.1976.01630330034009

10.1038/clpt.1990.204

10.7326/0003-4819-72-4-521

10.1001/archderm.1977.01640050070009

10.1016/S0140-6736(84)90949-8

10.1111/j.1365-2133.1983.tb04583.x

10.1111/j.1365-2133.1973.tb07516.x

10.1111/j.1365-2125.1990.tb05448.x

Uetrecht J. P., 1988, Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells, J. Pharmac. exp. Ther., 245, 274

Wright J. T., 1984, Cimetidine and dapsone acetylation, Drug. Metab. Disp., 12, 782

10.1016/1040-0486(91)90003-M

10.2165/00003088-198611040-00003

Thông tin
Thông tin xuất bản

British Journal of Clinical Pharmacology

Tập 34 Số 3

244-249

Thông tin tác giả